Cadus Reports 2011 Results

Cadus Reports 2011 Results

ID: 130457

(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 03/30/12 -- (OTCBB: KDUS) announced today financial results for the full year ended December 31, 2011.

Revenues for the full year 2011 were $0, compared to $100,000 for the full year 2010. Net loss for the full year 2011 was $503,391, compared to net loss of $400,812 for the full year 2010. Basic and diluted net loss per share for the full year 2011 was $0.04, compared to basic and diluted net loss per share for the full year 2010 of $0.03. The increase in net loss is attributable to no license fees received in 2011 as compared to a license fee in 2010 of $100,000, a decrease in interest income of $15,534, an increase in loss from equity in other ventures of $184, costs in connection with an abandoned potential acquisition of $59,177, a decrease in miscellaneous income of $3,752, an increase in franchise tax of $3,340, offset by a decrease in general and administrative expenses of $79,408.

As of December 31, 2011, Cadus had 13,144,040 shares outstanding.

This press release may contain forward-looking statements that involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in the company's annual report on Form 10-K for the year ended December 31, 2011. These include risks and uncertainties relating to the company's ability to license its technologies to third parties, the company's capital needs and uncertainty of future funding, the company's history of operating losses, the unpredictability of patent protection and the risk of obsolescence of the company's technologies.







Contact:
David Blitz
(212) 575-7800




Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Data From AVI BioPharma's Infectious Disease Programs to Be Presented at the 22nd European Congress of Clinical Microbiology and Infectious Diseases Pivotal Therapeutics Inc. Grants Incentive Stock Options
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 30.03.2012 - 14:02 Uhr
Sprache: Deutsch
News-ID 130457
Anzahl Zeichen: 0

contact information:
Town:

NEW YORK, NY



Kategorie:

Drugs



Diese Pressemitteilung wurde bisher 277 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Cadus Reports 2011 Results"
steht unter der journalistisch-redaktionellen Verantwortung von

Cadus (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Cadus Announces New Corporate Web-Site ...

NEW YORK, NY -- (Marketwired) -- 12/09/15 -- (OTCBB: KDUS) announced today that it has established its new corporate web-site, CadusCorp.com. The website currently permits the visitor to view the location of certain of the company's properties ...

Cadus Reports Third Quarter 2013 Results ...

NEW YORK, NY -- (Marketwired) -- 11/05/13 -- (OTCBB: KDUS) announced today financial results for the third quarter ended September 30, 2013.Revenues were $0 for the third quarter of 2013 and for the same period in 2012. Net loss for the third quarte ...

Cadus Reports Second Quarter 2013 Results ...

NEW YORK, NY -- (Marketwired) -- 08/14/13 -- (OTCBB: KDUS) announced today financial results for the second quarter ended June 30, 2013.Revenues were $0 for the second quarter of 2013 and for the same period in 2012. Net loss for the second quarter ...

Alle Meldungen von Cadus



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z